Department of Pharmacology and Center for Biomedical Neuroscience, UT Health San Antonio, San Antonio, Texas, USA.
South Texas Veterans Health Care System, Audie L. Murphy Division, San Antonio, Texas, USA.
Int J Neuropsychopharmacol. 2022 Aug 16;25(8):688-698. doi: 10.1093/ijnp/pyac035.
Up to 64% of patients diagnosed with posttraumatic stress disorder (PTSD) experience psychosis, likely attributable to aberrant dopamine neuron activity. We have previously demonstrated that positive allosteric modulators of α5-GABAARs can selectively decrease hippocampal activity and reverse psychosis-like physiological and behavioral alterations in a rodent model used to study schizophrenia; however, whether this approach translates to a PTSD model remains to be elucidated.
We utilized a 2-day inescapable foot shock (IS) procedure to induce stress-related pathophysiology in male Sprague-Dawley rats. We evaluated the effects of intra-ventral hippocampus (vHipp) administration GL-II-73, an α5-GABAAR, or viral overexpression of the α5 subunit, using in vivo electrophysiology and behavioral measures in control and IS-treated rats.
IS significantly increased ventral tegmental area dopamine neuron population activity, or the number of dopamine neurons firing spontaneously (n = 6; P = .016), consistent with observation in multiple rodent models used to study psychosis. IS also induced deficits in sensorimotor gating, as measured by reduced prepulse inhibition of startle (n = 12; P = .039). Interestingly, intra-vHipp administration of GL-II-73 completely reversed IS-induced increases in dopamine neuron population activity (n = 6; P = .024) and deficits in prepulse inhibition (n = 8; P = .025), whereas viral overexpression of the α5 subunit in the vHipp was not effective.
Our results demonstrate that pharmacological intervention augmenting α5-GABAAR function, but not α5 overexpression in itself, can reverse stress-induced deficits related to PTSD in a rodent model, providing a potential site of therapeutic intervention to treat comorbid psychosis in PTSD.
多达 64%的创伤后应激障碍 (PTSD) 患者出现精神病,可能归因于多巴胺神经元活动异常。我们之前的研究表明,α5-GABAAR 的正变构调节剂可以选择性地降低海马体的活性,并逆转精神分裂症啮齿动物模型中类似精神病的生理和行为改变;然而,这种方法是否适用于 PTSD 模型仍有待阐明。
我们利用为期两天的不可逃避的足底电击 (IS) 程序,在雄性 Sprague-Dawley 大鼠中诱导与应激相关的病理生理学。我们通过在体电生理学和行为测量评估了腹侧海马体 (vHipp) 内注射 GL-II-73(一种 α5-GABAAR)或病毒过表达 α5 亚基对对照组和 IS 处理大鼠的影响。
IS 显著增加腹侧被盖区多巴胺神经元群体活性,或自发放电的多巴胺神经元数量(n=6;P=0.016),与用于研究精神病的多种啮齿动物模型中的观察结果一致。IS 还导致感觉运动门控缺陷,表现为惊跳反射的前脉冲抑制减少(n=12;P=0.039)。有趣的是,GL-II-73 静脉内注射完全逆转了 IS 诱导的多巴胺神经元群体活性增加(n=6;P=0.024)和前脉冲抑制缺陷(n=8;P=0.025),而 vHipp 中的 α5 亚基病毒过表达则无效。
我们的结果表明,增强 α5-GABAAR 功能的药物干预,而不是 α5 过表达本身,可以逆转 PTSD 啮齿动物模型中应激诱导的缺陷,为治疗 PTSD 共病精神病提供了潜在的治疗干预靶点。